Concepedia

Publication | Closed Access

Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.

127

Citations

0

References

1994

Year

Michael P. Meyer, J. Meyer, A. Commerford, F M Hann, A A Sive, Peter Jacobs, A. F. Malan
PubMed

Abstract

Using a dose of rHuEpo of 600 U/kg per week, this study has shown a clear reduction in the requirement for blood transfusion in preterm infants.